2023-2029 Global Group A and Group C Meningococcal Polysaccharide Vaccine Industry Research & Trends Analysis Report
2023-2029 Global Group A and Group C Meningococcal Polysaccharide Vaccine Industry Research & Trends Analysis Report
Insights into the Group A and Group C Meningococcal Polysaccharide Vaccine Market include supply chain optimization, Group A and Group C Meningococcal Polysaccharide Vaccine challenges, and growth forecasts segmented by region and service type.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to the research report, the global market for Group A and Group C Meningococcal Polysaccharide Vaccine should grow from US$ 285 million in 2022 to US$ 425.5 million by 2029, with a CAGR of 5.9% for the period of 2023-2029.
Meningococcal disease, caused by Neisseria meningitidis, can cause serious illness and even death. The global burden of meningococcal disease, especially serogroups A and C, drives the need for effective vaccines to prevent these infections.
After vaccination, the body can produce a humoral immune response. It is used to prevent infectious diseases caused by group A and group C meningococci, such as cerebrospinal meningitis and pneumonia.
This report aims to provide a comprehensive study of the global market for Group A and Group C Meningococcal Polysaccharide Vaccine. Report Highlights:
(1) Global Group A and Group C Meningococcal Polysaccharide Vaccine market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Group A and Group C Meningococcal Polysaccharide Vaccine market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Group A and Group C Meningococcal Polysaccharide Vaccine market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Group A and Group C Meningococcal Polysaccharide Vaccine segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Group A and Group C Meningococcal Polysaccharide Vaccine segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Group A and Group C Meningococcal Polysaccharide Vaccine, capacity, production and trends.
(7) Group A and Group C Meningococcal Polysaccharide Vaccine industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Class 1 Vaccine
Class II Vaccine
Market segment by application, can be divided into
Hospital
Clinic
Market segment by players, this report covers
Walvax
Lanzhou Institute of Biological Products
AIM Bio
Sanofi Pasteur
GSK
Hualan Bio
ZFSW
Changsheng
Kanghua Bio
1 Market Overview
1.1 Group A and Group C Meningococcal Polysaccharide Vaccine Definition
1.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Forecast
1.2.1 By Revenue, Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
1.2.2 By Sales Volume, Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
1.2.3 Global Group A and Group C Meningococcal Polysaccharide Vaccine Price Trend, 2018-2029
1.3 China Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Forecast
1.3.1 By Revenue, China Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
1.3.2 By Sales Volume, China Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
1.3.3 China Group A and Group C Meningococcal Polysaccharide Vaccine Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Group A and Group C Meningococcal Polysaccharide Vaccine Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Group A and Group C Meningococcal Polysaccharide Vaccine Share in Global Market, 2018-2029
1.4.3 Group A and Group C Meningococcal Polysaccharide Vaccine Market Size: China VS Global, 2018-2029
1.5 Group A and Group C Meningococcal Polysaccharide Vaccine Market Dynamics
1.5.1 Group A and Group C Meningococcal Polysaccharide Vaccine Market Drivers
1.5.2 Group A and Group C Meningococcal Polysaccharide Vaccine Market Restraints
1.5.3 Group A and Group C Meningococcal Polysaccharide Vaccine Industry Trends
1.5.4 Group A and Group C Meningococcal Polysaccharide Vaccine Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue by Company, 2018-2023
2.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume by Company, 2018-2023
2.3 Global Group A and Group C Meningococcal Polysaccharide Vaccine Price by Company, 2018-2023
2.4 Global Group A and Group C Meningococcal Polysaccharide Vaccine Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Group A and Group C Meningococcal Polysaccharide Vaccine Concentration Ratio
2.6 Global Group A and Group C Meningococcal Polysaccharide Vaccine Mergers & Acquisitions, Expansion Plans
2.7 Global Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Group A and Group C Meningococcal Polysaccharide Vaccine Revenue by Company, 2018-2023
3.2 China Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume by Company, 2018-2023
3.3 China Group A and Group C Meningococcal Polysaccharide Vaccine Group A and Group C Meningococcal Polysaccharide Vaccine Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Group A and Group C Meningococcal Polysaccharide Vaccine Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Group A and Group C Meningococcal Polysaccharide Vaccine Domestic VS Export
3.6 China Market, Group A and Group C Meningococcal Polysaccharide Vaccine Import & Export
3.6.1 China Market, Group A and Group C Meningococcal Polysaccharide Vaccine Import & Export, 2018-2029
3.6.2 China Group A and Group C Meningococcal Polysaccharide Vaccine Import & Export Trends
3.6.3 Main Sources of China Group A and Group C Meningococcal Polysaccharide Vaccine Import
3.6.4 Export Destination of China Group A and Group C Meningococcal Polysaccharide Vaccine
4 Group A and Group C Meningococcal Polysaccharide Vaccine Production by Region
4.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers
4.3 Global Major Manufacturers, Group A and Group C Meningococcal Polysaccharide Vaccine Capacity Expansion and Future Plans
4.4 Global Group A and Group C Meningococcal Polysaccharide Vaccine Capacity by Region
4.5 Global Group A and Group C Meningococcal Polysaccharide Vaccine Production by Region
4.5.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Production by Region, 2018-2023
4.5.3 Global Group A and Group C Meningococcal Polysaccharide Vaccine Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Group A and Group C Meningococcal Polysaccharide Vaccine Industry Chain
5.2 Group A and Group C Meningococcal Polysaccharide Vaccine Upstream Analysis
5.2.1 Group A and Group C Meningococcal Polysaccharide Vaccine Core Raw Materials
5.2.2 Main Manufacturers of Group A and Group C Meningococcal Polysaccharide Vaccine Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Group A and Group C Meningococcal Polysaccharide Vaccine Production Mode
5.6 Group A and Group C Meningococcal Polysaccharide Vaccine Procurement Model
5.7 Group A and Group C Meningococcal Polysaccharide Vaccine Industry Sales Model and Sales Channels
5.7.1 Group A and Group C Meningococcal Polysaccharide Vaccine Sales Model
5.7.2 Group A and Group C Meningococcal Polysaccharide Vaccine Typical Distributors
6 Sights by Type
6.1 Group A and Group C Meningococcal Polysaccharide Vaccine Classification
6.1.1 Class 1 Vaccine
6.1.2 Class II Vaccine
6.2 By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue, 2018-2029
6.4 By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, 2018-2029
6.5 By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Price, 2018-2029
7 Sights by Application
7.1 Group A and Group C Meningococcal Polysaccharide Vaccine Segment by Application
7.1.1 Hospital
7.1.2 Clinic
7.2 By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue, 2018-2029
7.4 By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, 2018-2029
7.5 By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue, 2018-2029
8.3 By Region, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Market Share
8.5 Europe
8.5.1 Europe Group A and Group C Meningococcal Polysaccharide Vaccine Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Market Share
8.7 South America
8.7.1 South America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size & CAGR，2018 VS 2022 VS 2029
9.2 By Country, Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue, 2018-2029
9.3 By Country, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
9.4.2 By Company, U.S. Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
9.5.2 By Company, Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022
9.5.3 By Type, Europe Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
9.6.2 By Company, China Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022
9.6.3 By Type, China Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
9.7.2 By Company, Japan Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022
9.7.3 By Type, Japan Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
9.8.2 By Company, South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
9.10.2 By Company, India Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022
9.10.3 By Type, India Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Walvax
10.1.1 Walvax Company Information, Head Office, Market Area and Industry Position
10.1.2 Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications and Application
10.1.3 Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Walvax Company Profile and Main Business
10.1.5 Walvax Recent Developments
10.2 Lanzhou Institute of Biological Products
10.2.1 Lanzhou Institute of Biological Products Company Information, Head Office, Market Area and Industry Position
10.2.2 Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications and Application
10.2.3 Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Lanzhou Institute of Biological Products Company Profile and Main Business
10.2.5 Lanzhou Institute of Biological Products Recent Developments
10.3 AIM Bio
10.3.1 AIM Bio Company Information, Head Office, Market Area and Industry Position
10.3.2 AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications and Application
10.3.3 AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 AIM Bio Company Profile and Main Business
10.3.5 AIM Bio Recent Developments
10.4 Sanofi Pasteur
10.4.1 Sanofi Pasteur Company Information, Head Office, Market Area and Industry Position
10.4.2 Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications and Application
10.4.3 Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Sanofi Pasteur Company Profile and Main Business
10.4.5 Sanofi Pasteur Recent Developments
10.5 GSK
10.5.1 GSK Company Information, Head Office, Market Area and Industry Position
10.5.2 GSK Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications and Application
10.5.3 GSK Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 GSK Company Profile and Main Business
10.5.5 GSK Recent Developments
10.6 Hualan Bio
10.6.1 Hualan Bio Company Information, Head Office, Market Area and Industry Position
10.6.2 Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications and Application
10.6.3 Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Hualan Bio Company Profile and Main Business
10.6.5 Hualan Bio Recent Developments
10.7 ZFSW
10.7.1 ZFSW Company Information, Head Office, Market Area and Industry Position
10.7.2 ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications and Application
10.7.3 ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 ZFSW Company Profile and Main Business
10.7.5 ZFSW Recent Developments
10.8 Changsheng
10.8.1 Changsheng Company Information, Head Office, Market Area and Industry Position
10.8.2 Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications and Application
10.8.3 Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Changsheng Company Profile and Main Business
10.8.5 Changsheng Recent Developments
10.9 Kanghua Bio
10.9.1 Kanghua Bio Company Information, Head Office, Market Area and Industry Position
10.9.2 Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications and Application
10.9.3 Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Kanghua Bio Company Profile and Main Business
10.9.5 Kanghua Bio Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Tables & Figures:
Table 1. Group A and Group C Meningococcal Polysaccharide Vaccine Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Group A and Group C Meningococcal Polysaccharide Vaccine Market Restraints
Table 3. Group A and Group C Meningococcal Polysaccharide Vaccine Market Trends
Table 4. Group A and Group C Meningococcal Polysaccharide Vaccine Industry Policy
Table 5. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue by Company, 2018-2023, US$ million
Table 6. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share by Company, 2018-2023
Table 7. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share by Company, 2018-2023
Table 9. Global Group A and Group C Meningococcal Polysaccharide Vaccine Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Group A and Group C Meningococcal Polysaccharide Vaccine Mergers & Acquisitions, Expansion Plans
Table 12. Global Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers Product Type
Table 13. China Group A and Group C Meningococcal Polysaccharide Vaccine Revenue by Company, 2018-2023, US$ million
Table 14. China Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share by Company, 2018-2023
Table 15. China Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Group A and Group C Meningococcal Polysaccharide Vaccine Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Group A and Group C Meningococcal Polysaccharide Vaccine Import & Export Trends
Table 19. Main Sources of China Group A and Group C Meningococcal Polysaccharide Vaccine Import
Table 20. Export Destination of China Group A and Group C Meningococcal Polysaccharide Vaccine
Table 21. Global Headquarters and Manufacturing Base of Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers
Table 22. Global Major Manufacturers, Group A and Group C Meningococcal Polysaccharide Vaccine Capacity Expansion and Future Plans
Table 23. Global Group A and Group C Meningococcal Polysaccharide Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Group A and Group C Meningococcal Polysaccharide Vaccine Production by Region, 2018-2023, (K Units)
Table 25. Global Group A and Group C Meningococcal Polysaccharide Vaccine Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Group A and Group C Meningococcal Polysaccharide Vaccine Upstream (Raw Materials)
Table 27. Global Group A and Group C Meningococcal Polysaccharide Vaccine Typical Customers
Table 28. Group A and Group C Meningococcal Polysaccharide Vaccine Typical Distributors
Table 29. By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share, 2018-2029
Table 37. By Country, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2018-2029
Table 39. Walvax Company Information, Head Office, Market Area and Industry Position
Table 40. Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications and Application
Table 41. Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Walvax Company Profile and Main Business
Table 43. Walvax Recent Developments
Table 44. Lanzhou Institute of Biological Products Company Information, Head Office, Market Area and Industry Position
Table 45. Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications and Application
Table 46. Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Lanzhou Institute of Biological Products Company Profile and Main Business
Table 48. Lanzhou Institute of Biological Products Recent Developments
Table 49. AIM Bio Company Information, Head Office, Market Area and Industry Position
Table 50. AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications and Application
Table 51. AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. AIM Bio Company Profile and Main Business
Table 53. AIM Bio Recent Developments
Table 54. Sanofi Pasteur Company Information, Head Office, Market Area and Industry Position
Table 55. Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications and Application
Table 56. Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Sanofi Pasteur Company Profile and Main Business
Table 58. Sanofi Pasteur Recent Developments
Table 59. GSK Company Information, Head Office, Market Area and Industry Position
Table 60. GSK Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications and Application
Table 61. GSK Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. GSK Company Profile and Main Business
Table 63. GSK Recent Developments
Table 64. Hualan Bio Company Information, Head Office, Market Area and Industry Position
Table 65. Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications and Application
Table 66. Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Hualan Bio Company Profile and Main Business
Table 68. Hualan Bio Recent Developments
Table 69. ZFSW Company Information, Head Office, Market Area and Industry Position
Table 70. ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications and Application
Table 71. ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. ZFSW Company Profile and Main Business
Table 73. ZFSW Recent Developments
Table 74. Changsheng Company Information, Head Office, Market Area and Industry Position
Table 75. Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications and Application
Table 76. Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Changsheng Company Profile and Main Business
Table 78. Changsheng Recent Developments
Table 79. Kanghua Bio Company Information, Head Office, Market Area and Industry Position
Table 80. Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications and Application
Table 81. Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Kanghua Bio Company Profile and Main Business
Table 83. Kanghua Bio Recent Developments
List of Figure
Figure 1. Group A and Group C Meningococcal Polysaccharide Vaccine Picture
Figure 2. By Revenue, Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Group A and Group C Meningococcal Polysaccharide Vaccine Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Group A and Group C Meningococcal Polysaccharide Vaccine Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Group A and Group C Meningococcal Polysaccharide Vaccine Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Group A and Group C Meningococcal Polysaccharide Vaccine Share of Global Market, 2018-2029
Figure 10. Global Group A and Group C Meningococcal Polysaccharide Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Group A and Group C Meningococcal Polysaccharide Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Group A and Group C Meningococcal Polysaccharide Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Group A and Group C Meningococcal Polysaccharide Vaccine Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Group A and Group C Meningococcal Polysaccharide Vaccine Domestic VS Export, 2022
Figure 16. Global Group A and Group C Meningococcal Polysaccharide Vaccine Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Group A and Group C Meningococcal Polysaccharide Vaccine Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Group A and Group C Meningococcal Polysaccharide Vaccine Production Market Share & Forecast by Region, 2018-2029
Figure 19. Group A and Group C Meningococcal Polysaccharide Vaccine Industry Chain
Figure 20. Group A and Group C Meningococcal Polysaccharide Vaccine Procurement Model
Figure 21. Group A and Group C Meningococcal Polysaccharide Vaccine Sales Model
Figure 22. Group A and Group C Meningococcal Polysaccharide Vaccine Sales Channels, Direct Sales and Distribution
Figure 23. Class 1 Vaccine
Figure 24. Class II Vaccine
Figure 25. By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue, 2018-2029, US$ Million
Figure 26. By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share, 2018-2029
Figure 27. By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, 2018-2029, (K Units)
Figure 28. By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2018-2029
Figure 29. By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Price, 2018-2029, (US$/Unit)
Figure 30. Hospital
Figure 31. Clinic
Figure 32. By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue, 2018-2029, US$ Million
Figure 33. By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share, 2018-2029
Figure 34. By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, 2018-2029, (K Units)
Figure 35. By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2018-2029
Figure 36. By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Price, 2018-2029, (US$/Unit)
Figure 37. By Region, Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share, 2018-2029
Figure 38. By Region, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2018-2029
Figure 39. North America Group A and Group C Meningococcal Polysaccharide Vaccine Revenue & Forecasts, 2018-2029, US$ Million
Figure 40. By Country, North America Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share, 2022
Figure 41. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Revenue & Forecasts, 2018-2029, US$ Million
Figure 42. By Country, Europe Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share, 2022
Figure 43. Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Revenue & Forecasts, 2018-2029, US$ Million
Figure 44. By Country/Region, Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share, 2022
Figure 45. South America Group A and Group C Meningococcal Polysaccharide Vaccine Revenue & Forecasts, 2018-2029, US$ Million
Figure 46. By Country, South America Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share, 2022
Figure 47. Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine Revenue & Forecasts, 2018-2029, US$ Million
Figure 48. U.S. Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, 2018-2029, (K Units)
Figure 49. By Company, U.S. Group A and Group C Meningococcal Polysaccharide Vaccine Market Share, 2022
Figure 50. By Type, U.S. Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 51. By Application, U.S. Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 52. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, 2018-2029, (K Units)
Figure 53. By Company, Europe Group A and Group C Meningococcal Polysaccharide Vaccine Market Share, 2022
Figure 54. By Type, Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 55. By Application, Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 56. China Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, 2018-2029, (K Units)
Figure 57. By Company, China Group A and Group C Meningococcal Polysaccharide Vaccine Market Share, 2022
Figure 58. By Type, China Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 59. By Application, China Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 60. Japan Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, 2018-2029, (K Units)
Figure 61. By Company, Japan Group A and Group C Meningococcal Polysaccharide Vaccine Market Share, 2022
Figure 62. By Type, Japan Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 63. By Application, Japan Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 64. South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, 2018-2029, (K Units)
Figure 65. By Company, South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Market Share, 2022
Figure 66. By Type, South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 67. By Application, South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 68. Southeast Asia Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, 2018-2029, (K Units)
Figure 69. By Company, Southeast Asia Group A and Group C Meningococcal Polysaccharide Vaccine Market Share, 2022
Figure 70. By Type, Southeast Asia Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 71. By Application, Southeast Asia Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 72. India Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, 2018-2029, (K Units)
Figure 73. By Company, India Group A and Group C Meningococcal Polysaccharide Vaccine Market Share, 2022
Figure 74. By Type, India Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 75. By Application, India Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 76. Middle East & Asia Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, 2018-2029, (K Units)
Figure 77. By Company, Middle East & Asia Group A and Group C Meningococcal Polysaccharide Vaccine Market Share, 2022
Figure 78. By Type, Middle East & Asia Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 79. By Application, Middle East & Asia Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 80. Research Methodology
Figure 81. Breakdown of Primary Interviews
Figure 82. Bottom-up Approaches
Figure 83. Top-down Approaches
Research Methodology:
Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|